跳至主要内容
临床试验/NCT07076043
NCT07076043招募中4 期

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2025年6月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
1,400
试验地点
1
主要终点
PrEP initiation

研究概览

简要总结

Following on the heels of large implementation science projects that participated in the launch of widespread daily oral PrEP availability, investigators will launch and study the integration of novel PrEP products - beginning with the dapivirine ring- into existing PrEP programs that reach women seeking reproductive health care at health facilities in Kenya. Intervention delivery will be launched among 12 participating clinics with approximately 1400 AGYW seeking reproductive health services and counseled about PrEP through a stepped wedge cluster randomized trial. investigators will support participating clinics to add dapivirine ring into their existing PrEP services offered to women seeking reproductive health care. The primary aim of the study will be to determine whether the availability of multiple PrEP products to young women will result in greater frequency of PrEP initiation and persistence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •for Adolescent Girls and Young Women seeking reproductive health services:
  • •Age ≥18 years and ≤30years. Seeking a reproductive health service from one of the project facilities (reproductive health services include but are not limited to family planning, maternal and child health, postnatal care).
  • •AGYW receiving reproductive health-related services through OPD, or other departments are eligible. AGYW receiving reproductive health-related services through other departments are eligible.
  • •Willing and able to partake in an informed consent process. Able to speak and read in Kiswahili or English.

排除标准

  • 未提供

研究组 & 干预措施

Multiple Product PrEP Program

Experimental

In the intervention phase, clinics will offer a multi-product PrEP program, which includes daily oral PrEP and other forms of PrEP that are available. To start, the dapivirine vaginal ring will be included among the other forms of PrEP that are available. Others will be added as they become available in Kenya.

干预措施: Multiple Product PrEP Program (Drug)

Routine PrEP Program

Active Comparator

In the active comparator, clinics will offer the standard of care PrEP Program, which includes daily oral PrEP for young women.

干预措施: Routine Oral PrEP (Drug)

Multiple Product PrEP Program

Experimental

In the intervention phase, clinics will offer a multi-product PrEP program, which includes daily oral PrEP and other forms of PrEP that are available. To start, the dapivirine vaginal ring will be included among the other forms of PrEP that are available. Others will be added as they become available in Kenya.

干预措施: Routine Oral PrEP (Drug)

结局指标

主要结局

PrEP initiation

时间窗: From enrolment to 6 months

Women who start to use PrEP

次要结局

  • PrEP persistence at 3 months(From enrolment to 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Renee Heffron

Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验